Adjuvants to L-dopa for Parkinsonism.
作者信息
Braham J
出版信息
Br Med J. 1970 May 30;2(5708):540. doi: 10.1136/bmj.2.5708.540.
Abstract
摘要
相似文献
1
Adjuvants to L-dopa for Parkinsonism.
Br Med J. 1970 May 30;2(5708):540. doi: 10.1136/bmj.2.5708.540.
2
[Disulfiram and L-dopa in patients with Parkinson's syndrome and in torsion dystonia].
Prensa Med Mex. 1972 Jul-Aug;37(7):246-50.
3
[Treatment of parkinsonism with L-Dopa associated with decarboxylase inhibitors. II].
Rev Neurol (Paris). 1970 Nov;123(5):297-319.
4
[Use of Levo-Dopa in the treatment of Parkinsonism (188 cases)].
Minerva Neurochir. 1970 Apr-Sep;14(2):245-9.
5
L-dopa and amantadine in the therapy of parkinsonism.
Wis Med J. 1969 Nov;68(11):325-8.
6
[Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
Rev Med Chil. 1973 Jun;101(6):452-5.
7
Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).
Trans Am Neurol Assoc. 1971;96:55-8.
8
[Modalities of treatment of Parkinsonian syndrome with L-dopa].
Int J Neurol. 1972;9(1):23-32.
9
[Therapy of parkinsonian syndromes and plasmatic DOPA levels. Effects of L-DOPA and 3-OMD, administered alone or combined, with or without a decarboxylase inhibitor].
Rev Eur Etud Clin Biol. 1972 Jan;17(1):38-44.
10
[Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
Schweiz Med Wochenschr. 1970 May 9;100(19):797-804.
引用本文的文献
1
Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.
Drugs. 1973;6(5):364-88. doi: 10.2165/00003495-197306050-00004.
本文引用的文献
1
Metabolic pathways of dopamine and norepinephrine in rabbit brain in vitro.
J Pharmacol Exp Ther. 1967 Sep;157(3):493-502.
2
L-dopa in parkinson's syndrome.
N Engl J Med. 1969 Jul 31;281(5):272. doi: 10.1056/NEJM196907312810518.
3
Dopa-induced excitement in the cat. Its relationship to brain norepinephrine concentrations.
Arch Neurol. 1970 Jan;22(1):31-9. doi: 10.1001/archneur.1970.00480190035006.
Zotero 插件